Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: DENNY WILSON - CYTOKINE PHARMASCIENCES INC.


(WAC WAC (Women's Army Corps), U.S. army organization created (1942) during World War II to enlist women as auxiliaries for noncombatant duty in the U.S. army. Before 1943 it was known as the Women's Auxiliary Army Corps (WAAC). Its first director was Oveta Culp Hobby. 625) DENNY WILSON - CYTOKINE PHARMASCIENCES INC. Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 11/24/03. Complete text approximately 3000 words. Document # WAC625.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: information@twst.com.

***
COPYRIGHT 2003 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Nov 24, 2003
Words:85
Previous Article:CEO INTERVIEW: JEREMY ORD - DIMENSION DATA HOLDINGS.
Next Article:CEO INTERVIEW: MICHAEL SILTON - RAINMAKER SYSTEMS INC (RMKR).
Topics:



Related Articles
Charles Bugg, Ph.D. Awarded 1994 Milstein Award for Research in Human Interferon Gamma.
EntreMed, Inc. acquires Innovative Therapeutics, Inc.; company forms subsidiary named Cytokine Sciences, Inc.
Cytokine PharmaSciences Forms Joint Venture With Elan to Develop Cytokine Inhibitor.
Cytokine PharmaSciences Names Dennis F. Willson President and CEO; Willson also Appointed to Company Board of Directors.
Dyax Announces Collaboration with Baxter to Discover Anti-MIF Antibody.
Beijing Med-Pharm Corporation and Cytokine PharmaSciences, Inc. Reach Agreement to Distribute the Cervidil(R) Vaginal Insert Throughout the People's...
Beijing Med-Pharm Corporation and Cytokine PharmaSciences, Inc. Reach Agreement on Development and Commercialization of Second-Generation Obstetrics...
Presidio Pharmaceuticals Licenses Nuclear Exclusion Compounds from Cytokine PharmaSciences.
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles